We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Results Of Phase IIb Clinical Trial Of Short Ragweed Sublingual-Oral Immunotherapy At American Academy Of Allergy Asthma And Immunology Annual Meeting
Allergy Greer, a leading developer and provider of allergy immunotherapy products, today announced the results of its Phase IIb double-blind placebo-controlled dose response trial for the sublingual-oral immunotherapy (SLIT) administration of its standardized short ragweed pollen extract. According to the study, sublingual-oral immunotherapy was safe and effective in reducing rhinoconjunctivitis and need for anti-allergy medications. Robert Esch, Ph.D.
Custom Search
